Neurology & Rare Disorders

Huntington’s Disease (HD)

Huntington’s Disease (HD) is a rare, inherited neurological disorder that progressively affects movement, cognition, and behavior. CenExel partners with sponsors to advance innovative therapies through expert clinical research, specialized patient recruitment, and compassionate care for individuals and families impacted by HD.

Studies Conducted
0 +
Trial Participants
0 +
Active Centers
0
Overview

Advancing Huntington’s Disease Clinical Research

CenExel’s experienced neuroscience research teams support Huntington’s Disease clinical trials with specialized operational expertise, patient-centered care, and advanced site capabilities. Our investigators work closely with sponsors to accelerate innovative therapies from early-phase studies through late-stage clinical development.

Specialized Neurology Expertise

Our experienced investigators and coordinators support complex CNS and neurodegenerative studies with precision and compassionate patient care.

Accelerated Patient Recruitment

Access to diverse patient populations and caregiver networks helps improve enrollment efficiency for HD clinical trials.
Conditions Covered

Huntington’s Disease Conditions We Research

Our neurology research sites support a broad range of Huntington’s Disease-related symptoms and associated neurodegenerative conditions.

  • Huntington’s Disease (HD)
  • Early-Stage Huntington’s Disease
  • Juvenile Huntington’s Disease
  • Cognitive Impairment in HD
  • Behavioral & Psychiatric Symptoms
  • Movement Disorders
  • Chorea Associated with HD
  • Neurodegenerative Disorders
Our Approach

Why Sponsors Choose CenExel for Huntington’s Disease Research

CenExel provides scientific leadership, operational excellence, and experienced neurology research teams to support successful Huntington’s Disease clinical trials.

01

CNS Research Expertise

Our teams specialize in complex neurology and neurodegenerative clinical trials.

02

Biomarker & Imaging Support

Advanced imaging and biomarker capabilities help support data-driven clinical outcomes.

03

Patient-Centered Care

Dedicated coordinators and caregiver support improve patient engagement and retention.

04

Diverse Research Network

CenExel’s nationwide site network enables broader access to HD patient populations.

Phase Coverage

Supported Trial Phases

CenExel supports Huntington’s Disease research across early and late-stage clinical development programs.

Active across all phases
  • Phase I
  • Phase II
  • Phase III
  • Phase IV

Our neurology research teams support first-in-human studies, proof-of-concept trials, biomarker validation, and large multicenter HD studies with operational precision and scientific expertise.

Let’s Advance Your Next Study

Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.

Explore Our Network

Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.

Our Blog